CPHI & PMEC Shenzhen 2024 is a premier exhibition in the pharmaceutical industry, showcasing products such as pharma ingredients and excipients, bioengineering, laboratory instruments and equipment, clean technology, packaging, and more. This event fosters innovative advancements and new opportunities in the Greater Bay Area and Asia’s pharmaceutical sector.
The Guangdong-Hong Kong-Macao Greater Bay Area is one of the most open and economically vibrant regions in China. Supported by national and local policies, it has evolved into a major hub for the biopharmaceutical industry, with a refined industry structure and significant global influence. By 2028, the Greater Bay Area’s health industry GDP is projected to reach 2 trillion RMB, expanding to 2.5 to 3 trillion RMB by 2030.
The first edition in Guangzhou attracted 253 exhibitors and 5,308 visitors from 35 countries, providing an efficient platform for communication and procurement across the pharma supply chain. This event aids Chinese pharmaceutical companies in expanding into the Greater Bay Area and Pan Asian markets.
The second edition, hosted in Shenzhen from September 9 to 11, 2024, will continue to focus on pharmaceutical industry development in the Greater Bay Area and the broader Asian market. It will highlight industry transformation through advancements in new drug research, process technology innovations, and a precise, technology-driven platform fostering industry collaborations.
CPHI & PMEC Shenzhen 2024 by the Numbers:
Key Products to be Presented:
Target Industries:
Join us from September 9-11, 2024, in Shenzhen to connect with industry leaders, explore innovative pharmaceutical solutions, and expand your business network. Register now to secure your place at CPHI & PMEC Shenzhen 2024!